When was Disto Pharmaceuticals founded?

Disto Pharmaceuticals was founded in 2002.

Where is Disto Pharmaceuticals located?

Disto Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Plot No-22, Phase-I, Cherlapally Industrial Area, Hyderabad, Telangana, India, 500051.

How many employees does Disto Pharmaceuticals have?

As of Oct 31, 2024, the latest employee count at Disto Pharmaceuticals is 94.

Is Disto Pharmaceuticals a funded company?

Disto Pharmaceuticals is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Disto Pharmaceuticals?

Annual revenue of Disto Pharmaceuticals is ₹31.2Cr as on Mar 31, 2025.

Where does Disto Pharmaceuticals rank among its competitors?

Disto Pharmaceuticals ranks 16th amongst 74 active competitors, of which 2 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Famar, which secured $26.1M in Oct, 2024.

Who are the top competitors of Disto Pharmaceuticals?

Disto Pharmaceuticals' top competitors include Encube Ethicals, Famar and Crown Laboratories. Among them, Famar secured the most recent funding round in October, 2024.

Disto Pharmaceuticals - 2026 Company Profile & Competitors

Disto Pharmaceuticals is an unfunded company based in Hyderabad (India), founded in 2002. It operates as a Pharmaceuticals company that specializes in developing and manufacturing a range of semi-finished formulations, pellets, and granules. Disto Pharmaceuticals has not raised any funding yet. The company has 74 active competitors, including 2 funded and 18 that have exited. Its top competitors include companies like Encube Ethicals, Famar and Crown Laboratories.

Company Details

Disto Pharmaceuticals Pvt. Ltd. is a pharmaceutical manufacturing company that specializes in developing semi-finished formulations, pellets, and granules. The company is committed to providing high-quality products to meet the demands of the global pharmaceutical industry. With a strong presence in India, Disto Pharmaceuticals Pvt. Ltd. is well-positioned to capitalize on the growing demand for pharmaceutical products in emerging markets.

Website: distopharma.com
Registered Address: Plot No-22, Phase-I, Cherlapally Industrial Area, Hyderabad, Telangana, India, 500051

Key Metrics

Founded Year

2002

Location

Hyderabad, India

Stage

Unfunded

Ranked

16^th among 74 active competitors

Annual Revenue

₹31.2Cr as on Mar 31, 2025

Employee Count

94 as on Oct 31, 2024

Similar Companies

Encube Ethicals & 82 more

View Disto Pharmaceuticals' full profile

Disto Pharmaceuticals is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DISTO PHARMACEUTICALS PRIVATE LIMITED CIN: U24239TG2002PTC038926 , India, Active	May 09, 2002	$3.69M (As on Mar 31, 2025)	94 (As on Oct 31, 2024)

Disto Pharmaceuticals has not raised any funding rounds yet.

Disto Pharmaceuticals' employee count trend

Disto Pharmaceuticals has 94 employees as of Oct 24. The total employee count is 31.0% more than what it was in Oct 23. Here is Disto Pharmaceuticals's employee count trend over the years:

Employee count trend for Disto Pharmaceuticals

Uncover Disto Pharmaceuticals' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Disto Pharmaceuticals include Encube Ethicals, Famar and Crown Laboratories. Here is the list of Top 10 competitors of Disto Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Encube Ethicals 1998, Mumbai (India), Series D	Company offering contract development and manufacturing services for topical semisolid formulations	$65.5M	Quadria Capital, GII & 3 others	63/100
2nd	Famar 1949, Athens (Greece), Acquired	Contract manufacturing and development services provider	-	EBRD, Metric Capital & 1 others	58/100
3rd	Crown Laboratories 2000, Johnson City (United States), Acquired	Manufacturer of OTC, prescription, skin care and oral care products	-	Greenspring Associates, Montreux Equity Partners ... & 2 others	55/100
4th	Purna 1986, Puurs (Belgium), Acquired	CMO specializing in semi-solid and liquid dosage form manufacturing	-	-	48/100
5th	Curida 2015, Elverum (Norway), Seed	CDMO specialising in liquid pharmaceuticals and blow fill seal technology	$3.2M	Signet Healthcare Partners, Investinor & 1 others	46/100
6th	Accupac 1974, Baileyton (United States), Acquired	Company specializing in liquid contract manufacturing	-	-	42/100
7th	Formulated Solutions 1999, Largo (United States), Late Stage	CDMO partner delivering innovative solutions for pharmaceutical and consumer healthcare products	-	Linden Capital Partners, HealthEdge Investment Partners ... Read more	41/100
8th	Lyra Laboratories 2005, Chandigarh (India), Unfunded	Provider of dermatological, dental, and aesthetic condition solutions	-	-	40/100
9th	Chemineau Labs 1947, Vouvray (France), Acquired	CDMO specializing in ENT and topical dosage forms	-	Quilvest, Epiris	35/100
10th	Spatz Cosmeceuticals 2012, Ahmedabad (India), Unfunded	Developer of cosmoceutical products, also offering cosmoceutical contract manufacturing services	-	-	35/100
16th	Disto Pharmaceuticals 2002, Hyderabad (India), Unfunded	Pharmaceuticals company that specializes in developing and manufacturing a range of semi-finished formulations, pellets, and granules	-	-	40/100